These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34948066)

  • 1. Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.
    Stakhneva EM; Striukova EV; Ragino YI
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.
    Cooksley-Decasper S; Reiser H; Thommen DS; Biedermann B; Neidhart M; Gawinecka J; Cathomas G; Franzeck FC; Wyss C; Klingenberg R; Nanni P; Roschitzki B; Matter C; Wolint P; Emmert MY; Husmann M; Amann-Vesti B; Maier W; Gay S; Lüscher TF; von Eckardstein A; Hof D
    PLoS One; 2012; 7(10):e47985. PubMed ID: 23110151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in atherosclerosis.
    Martinez-Pinna R; Martin-Ventura JL; Mas S; Blanco-Colio LM; Tuñon J; Egido J
    Curr Atheroscler Rep; 2008 Jun; 10(3):209-15. PubMed ID: 18489848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular proteomics.
    Barderas MG; Vivanco F; Alvarez-Llamas G
    Methods Mol Biol; 2013; 1000():1-20. PubMed ID: 23585080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Architecture of Human Coronary and Aortic Atherosclerosis.
    Herrington DM; Mao C; Parker SJ; Fu Z; Yu G; Chen L; Venkatraman V; Fu Y; Wang Y; Howard TD; Jun G; Zhao CF; Liu Y; Saylor G; Spivia WR; Athas GB; Troxclair D; Hixson JE; Vander Heide RS; Wang Y; Van Eyk JE
    Circulation; 2018 Jun; 137(25):2741-2756. PubMed ID: 29915101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles.
    Navas-Carrillo D; Marín F; Valdés M; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):49-58. PubMed ID: 28013562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.
    Chang CT; Yang CY; Tsai FJ; Lin SY; Chen CJ
    Biomed Res Int; 2015; 2015():164846. PubMed ID: 26090384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic approach in the search of new cardiovascular biomarkers.
    Gallego-Delgado J; Lazaro A; Osende JI; Barderas MG; Blanco-Colio LM; Duran MC; Martin-Ventura JL; Vivanco F; Egido J
    Kidney Int Suppl; 2005 Dec; (99):S103-7. PubMed ID: 16336560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteomic approach in the development of prognostic biomarkers in atherothrombosis.
    Lorenzo O; Martín-Ventura JL; Blanco-Colio LM; Egido J; Tuñón J
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):25-30. PubMed ID: 19149703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic strategies in the search of new biomarkers in atherothrombosis.
    Tuñón J; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; López JA; Egido J
    J Am Coll Cardiol; 2010 May; 55(19):2009-16. PubMed ID: 20447523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin.
    Kristensen LP; Larsen MR; Mickley H; Saaby L; Diederichsen AC; Lambrechtsen J; Rasmussen LM; Overgaard M
    J Proteomics; 2014 Apr; 101():141-53. PubMed ID: 24369271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: rationale and design of the "Genetic Loci and the Burden of Atherosclerotic Lesions" study.
    Voros S; Maurovich-Horvat P; Marvasty IB; Bansal AT; Barnes MR; Vazquez G; Murray SS; Voros V; Merkely B; Brown BO; Warnick GR
    J Cardiovasc Comput Tomogr; 2014; 8(6):442-51. PubMed ID: 25439791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation.
    Han Y; Zhao S; Gong Y; Hou G; Li X; Li L
    Oncotarget; 2016 Jan; 7(2):1854-62. PubMed ID: 26636538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of atherosclerotic plaques: what we are learning from proteomic analysis.
    Blanco-Colio LM; Martín-Ventura JL; Vivanco F; Michel JB; Meilhac O; Egido J
    Cardiovasc Res; 2006 Oct; 72(1):18-29. PubMed ID: 16814757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human atheroma plaque secretome by proteomic analysis.
    Durán MC; Martín-Ventura JL; Mas S; Barderas MG; Dardé VM; Jensen ON; Egido J; Vivanco F
    Methods Mol Biol; 2007; 357():141-50. PubMed ID: 17172685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.